Wei Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Renal Cell Carcinoma

Top Venues

Cell death & disease

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Dongshan Chen, Haoyuan Cao, Xiang Zheng, Haojun Wang, Zengchi Han, Wei Wang
Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target. BMC cancer 24 (1) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Dongshan Chen, Haoyuan Cao, Xiang Zheng, Haojun Wang, Zengchi Han, Wei Wang
Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target. BMC cancer 24 (1) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Haojun Wang, Quanwei Zhou, Ding Fang Xie, Qingguo Xu, Tongwang Yang, Wei Wang
LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy. Cell death & disease 15 (2) (2024)
Qing Bi, Ji-Yue Wu, Xue-Meng Qiu, Yu-Qing Li, Yu-Yao Yan, Ze-Jia Sun, Wei Wang
Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and renal allograft failure: a machine learning-based exploration in the framework of predictive, preventive, and personalized medicine. The EPMA journal 14 (2) (2023)
Qing Bi, Ji-Yue Wu, Xue-Meng Qiu, Jian-Dong Zhang, Ze-Jia Sun, Wei Wang
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis. Journal of immunology research 2022 (2022)
Peng Cao, Ji-Yue Wu, Jian-Dong Zhang, Ze-Jia Sun, Xiang Zheng, Bao-Zhong Yu, Hao-Yuan Cao, Fei-Long Zhang, Zi-Hao Gao, Wei Wang
A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes. BMC cancer 22 (1) (2022)
Ze-Jia Sun, Zihao Gao, Ji-Yue Wu, Xiang Zheng, Shizhao Jing, Wei Wang
MSC-Derived Extracellular Vesicles Activate Mitophagy to Alleviate Renal Ischemia/Reperfusion Injury via the miR-223-3p/NLRP3 Axis. Stem cells international 2022 (2022)
Qianchuan Tian, Zhaoqi Zhang, Liang Tan, Fan Yang, Yanan Xu, Yinan Guo, Dong Wei, Changhong Wu, Peng Cao, Jiawei Ji, Wei Wang, Xubiao Xie, Yong Zhao
Skin and heart allograft rejection solely by long-lived alloreactive T RM cells in skin of severe combined immunodeficient mice. Science advances 8 (4) (2022)
Feilong Zhang, Jiyue Wu, Zejia Sun, Dawei Xie, Xiaoyong Yang, Wei Wang
Nephrogenic adenoma of the renal pelvis: A rare case report and review of the literature. Medicine 100 (34) (2021)
Baozhong Yu, Jiandong Zhang, Zejia Sun, Peng Cao, Xiang Zheng, Zihao Gao, Haoyuan Cao, Feilong Zhang, Wei Wang
Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis. Medicine 100 (1) (2021)
Jiyue Wu, Feilong Zhang, Jiandong Zhang, Zejia Sun, Changzhen Hao, Huawei Cao, Wei Wang
A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma. Technology in cancer research & treatment 20 (2021)